semaglutide patient assistance program Wegovy Medicare is expanding access to

October 2023: Researchers conducted a large observational study of about 5,400 patients who took semaglutide, liraglutide, or bupropion-naltrexone for weight loss

July 2, 2025: UK Launches Pancreatitis Study for Patients Who Take Trulicity and Other GLP-1s In the United Kingdom, there has been a concerning increase in the number of patients who are going to the hospital and dying of pancreatitis after taking GLP-1s like Trulicity

[PMID: 39902575] PubMed record related to this compound for laboratory literature review

Bottom line: a symptom becomes a pattern the moment it is logged next to dose day, food, and water instead of standing alone